Emma Barrett, M.D. joined Biologics Consulting as a Senior Clinical Consultant on Oct 1, 2015. Emma comes to Biologics Consulting with 15 years of clinical development experience in the pharmaceutical industry. She has held positions of increasing responsibility in a number of pharmaceutical companies, most recently as Senior Director, Clinical Research at Array BioPharma. In her most recent role, Emma oversaw the development of binimetinib from IND filing to pivotal Phase 3 studies. She was intimately involved in the strategic planning for the binimetinib program and for the studies conducted by Array BioPharma and their former co-development partner Novartis Pharmaceutical. In addition, she was the clinician overseeing all binimetinib clinical trials at Array Biopharma during her 6 years with the company. This involved protocol designs, sites selection, CROs selection, medical monitoring, data cleaning and analysis, clinical input on regulatory submissions and inquiries, CRA/study team/site/investigator education and training, organization of steering committees, data safety monitoring boards and advisory meetings, study and program level safety monitoring and participation in the global strategy team. Emma was the clinical lead for 4 additional oncology programs and 1 cardiology program during this time. She has extensive experience in the design, planning, implementation, oversight and analysis of first-in-human trials through global Phase 3 trials.
MD, Northwestern University School of Medical, Chicago, IL (1992)
BA, University of Illinois, Champaign-Urbana, IL (1986)
BA, Smith College, Northampton, MA (1984)